lobbying_activities: 2148192

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2148192	3410753d-cc8a-4763-a69c-3285f38e0040	Q2	CARMEN GROUP INCORPORATED	8316	BIOREFERENCE LABORATORIES, INC.	2018	second_quarter	MED	Delaying implementation of the Clinical Laboratory Fees Schedule; Support Local Coverage Determination process legislation; Concern about FDA regulation of clinical labs; Authorization of the 4K score test for prostrate cancer; MAC review of lab testing; National Coverage decision on genetic testing.	Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE	45000		0	0	2018-07-17T16:16:28.847000-04:00